메뉴 건너뛰기
Bosnian Journal of Basic Medical Sciences
Volumn 15, Issue 3, 2015, Pages 14-20
Dystrophin and the two related genetic diseases, duchenne and becker muscular dystrophies
Author keywords

Becker muscular dystrophy; Duchenne muscular dystrophy; Dystrophin; Exon skipping; Micro dystrophin
Indexed keywords

DYSTROPHIN;
EID: 84975104941     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2015.636     Document Type: Review
Times cited : (49)
References (84)
  • 1
    • 0024466501 scopus 로고
    • The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion
    • Koenig M, Beggs A, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989;45:498-506.
    • (1989) Am J Hum Genet , vol.45 , pp. 498-506
    • Koenig, M.1    Beggs, A.2    Moyer, M.3    Scherpf, S.4    Heindrich, K.5    Bettecken, T.6
  • 2
    • 0023614271 scopus 로고
    • Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
    • Jul 31
    • Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50:509-17. http://dx.doi.org/10.1016/0092-8674(87)90504-6.
    • (1987) Cell , vol.50 , pp. 509-517
    • Koenig, M.1    Hoffman, E.P.2    Bertelson, C.J.3    Monaco, A.P.4    Feener, C.5    Kunkel, L.M.6
  • 3
    • 0023632802 scopus 로고
    • Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis
    • Jan 30
    • Kenwrick S, Patterson M, Speer A, Fischbeck K, Davies K. Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis. Cell. 1987 Jan 30;48:351-7. http://dx.doi.org/10.1016/0092-8674(87)90438-7.
    • (1987) Cell , vol.48 , pp. 351-357
    • Kenwrick, S.1    Patterson, M.2    Speer, A.3    Fischbeck, K.4    Davies, K.5
  • 4
    • 71749114728 scopus 로고    scopus 로고
    • Mutational spectrum of DMD mutations in dystrophinopathy patients: Application of modern diagnostic techniques to a large cohort
    • Dec
    • Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat. 2009 Dec;30:1657-66. http://dx.doi.org/10.1002/humu.21114.
    • (2009) Hum Mutat , vol.30 , pp. 1657-1666
    • Flanigan, K.M.1    Dunn, D.M.2    Von Niederhausern, A.3    Soltanzadeh, P.4    Gappmaier, E.5    Howard, M.T.6
  • 5
    • 66349094547 scopus 로고    scopus 로고
    • Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: A model of nationwide knowledgebase
    • Jun
    • Tuffery-Giraud S, Beroud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, et al. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat. 2009 Jun;30:934-45. http://dx.doi.org/10.1002/humu.20976.
    • (2009) Hum Mutat , vol.30 , pp. 934-945
    • Tuffery-Giraud, S.1    Beroud, C.2    Leturcq, F.3    Yaou, R.B.4    Hamroun, D.5    Michel-Calemard, L.6
  • 6
    • 0023718118 scopus 로고
    • An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
    • Monaco A, Bertelson C, Liechti-Gallati S, Moser H, Kunkel L. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2:90-5. http://dx.doi.org/10.1016/0888-7543(88)90113-9.
    • (1988) Genomics , vol.2 , pp. 90-95
    • Monaco, A.1    Bertelson, C.2    Liechti-Gallati, S.3    Moser, H.4    Kunkel, L.5
  • 7
    • 84929957964 scopus 로고    scopus 로고
    • Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy
    • Wein N, Alfano L, Flanigan KM. Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy. Pediatr Clin N Am. 2015;62(3):723-42. http://dx.doi.org/10.1016/j.pcl.2015.03.008.
    • (2015) Pediatr Clin N Am , vol.62 , Issue.3 , pp. 723-742
    • Wein, N.1    Alfano, L.2    Flanigan, K.M.3
  • 8
    • 26944476254 scopus 로고    scopus 로고
    • Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy
    • Oct 15
    • Kohler M, Clarenbach CF, Boni L, Brack T, Russi EW, Bloch KE. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2005 Oct 15;172:1032-6. http://dx.doi.org/10.1164/rccm.200503-322OC.
    • (2005) Am J Respir Crit Care Med , vol.172 , pp. 1032-1036
    • Kohler, M.1    Clarenbach, C.F.2    Boni, L.3    Brack, T.4    Russi, E.W.5    Bloch, K.E.6
  • 9
    • 33749015734 scopus 로고    scopus 로고
    • Molecular mechanisms of muscular dystrophies: Old and new players
    • Oct
    • Davies KE, Nowak KJ. Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol. 2006 Oct;7:762-73. http://dx.doi.org/10.1038/nrm2024.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 762-773
    • Davies, K.E.1    Nowak, K.J.2
  • 10
    • 84878544086 scopus 로고    scopus 로고
    • The cell biology of disease: Cellular and molecular mechanisms underlying muscular dystrophy
    • May 13
    • Rahimov F, Kunkel LM. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol. 2013 May 13;201:499-510. http://dx.doi.org/10.1083/jcb.201212142
    • (2013) J Cell Biol , vol.201 , pp. 499-510
    • Rahimov, F.1    Kunkel, L.M.2
  • 11
    • 34250073609 scopus 로고
    • The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history
    • Feb
    • Bushby KM, Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J Neurol. 1993 Feb;240:98-104. http://dx.doi.org/10.1007/BF00858725.
    • (1993) J Neurol , vol.240 , pp. 98-104
    • Bushby, K.M.1    Gardner-Medwin, D.2
  • 12
    • 0027417446 scopus 로고
    • The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities
    • Feb
    • Bushby KM, Gardner-Medwin D, Nicholson LV, Johnson MA, Haggerty ID, Cleghorn NJ, et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol. 1993 Feb;240:105-12. http://dx.doi.org/10.1007/BF00858726.
    • (1993) J Neurol , vol.240 , pp. 105-112
    • Bushby, K.M.1    Gardner-Medwin, D.2    Nicholson, L.V.3    Johnson, M.A.4    Haggerty, I.D.5    Cleghorn, N.J.6
  • 14
    • 36248985708 scopus 로고    scopus 로고
    • Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
    • Dec
    • Neri M, Torelli S, Brown S, Ugo I, Sabatelli P, Merlini L, et al. Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human. Neuromuscul Disord. 2007 Dec;17:913-8. http://dx.doi.org/10.1016/j.nmd.2007.07.005.
    • (2007) Neuromuscul Disord , vol.17 , pp. 913-918
    • Neri, M.1    Torelli, S.2    Brown, S.3    Ugo, I.4    Sabatelli, P.5    Merlini, L.6
  • 15
    • 83755220617 scopus 로고    scopus 로고
    • Dystrophin quantification and clinical correlations in Becker muscular dystrophy: Implications for clinical trials
    • Dec
    • Anthony K, Cirak S, Torelli S, Tasca G, Feng L, Arechavala-Gomeza V, et al. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain. 2011 Dec;134:3544-56. http://dx.doi.org/10.1093/brain/awr291.
    • (2011) Brain , vol.134 , pp. 3544-3556
    • Anthony, K.1    Cirak, S.2    Torelli, S.3    Tasca, G.4    Feng, L.5    Arechavala-Gomeza, V.6
  • 17
    • 84927797280 scopus 로고    scopus 로고
    • Dystrophin and Duchenne dystrophy
    • May
    • Dubowitz V, Cohn RD. Dystrophin and Duchenne dystrophy. Neuromuscul Disord. 2015 May;25:361-2. http://dx.doi. org/10.1016/j.nmd.2015.03.013.
    • (2015) Neuromuscul Disord , vol.25 , pp. 361-362
    • Dubowitz, V.1    Cohn, R.D.2
  • 18
    • 0027548588 scopus 로고
    • Dystrophin and the membrane skeleton
    • Ervasti J, Campbell K. Dystrophin and the membrane skeleton. Curr Op Cell Biol. 1993;5:82-7. http://dx.doi.org/10.1016/S0955-0674(05)80012-2.
    • (1993) Curr Op Cell Biol , vol.5 , pp. 82-87
    • Ervasti, J.1    Campbell, K.2
  • 19
  • 20
    • 0026595121 scopus 로고
    • Binding sites involved in the interaction of actin with the N-terminal region of dystrophin
    • Levine BA, Moir AJG, Patchell VB, Perry SV. Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Letters. 1992;298:44-8. http://dx.doi. org/10.1016/0014-5793(92)80019-D.
    • (1992) FEBS Letters , vol.298 , pp. 44-48
    • Levine, B.A.1    Moir, A.2    Patchell, V.B.3    Perry, S.V.4
  • 21
    • 0033593116 scopus 로고    scopus 로고
    • The 2.0 A Structure of the Second Calponin Homology Domain from the Actin-binding Region of the Dystrophin Homologue Utrophin
    • Keep NH, Norwood FLM, Moores CA, Winder SJ, Kendrick-Jones J. The 2.0 A Structure of the Second Calponin Homology Domain from the Actin-binding Region of the Dystrophin Homologue Utrophin. J Mol Biol. 1999;285:1257-64. http://dx.doi.org/10.1006/jmbi.1998.2406.
    • (1999) J Mol Biol , vol.285 , pp. 1257-1264
    • Keep, N.H.1    Norwood, F.2    Moores, C.A.3    Winder, S.J.4    Kendrick-Jones, J.5
  • 22
    • 0034657791 scopus 로고    scopus 로고
    • The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy
    • Norwood F, Sutherland-Smith A, Keep N, Kendrick-Jones J. The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy. Structure. 2000;8:481-91. http://dx.doi. org/10.1016/S0969-2126(00)00132-5.
    • (2000) Structure , vol.8 , pp. 481-491
    • Norwood, F.1    Sutherland-Smith, A.2    Keep, N.3    Kendrick-Jones, J.4
  • 23
    • 0025217703 scopus 로고
    • Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility
    • Koenig M, Kunkel LM. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem. 1990;265:4560-6.
    • (1990) J Biol Chem , vol.265 , pp. 4560-4566
    • Koenig, M.1    Kunkel, L.M.2
  • 24
    • 0032561199 scopus 로고    scopus 로고
    • A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction
    • Amann KJ, Renley BA, Ervasti JM. A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction. J Biol Chem. 1998;273:28419-23. http://dx.doi. org/10.1074/jbc.273.43.28419.
    • (1998) J Biol Chem , vol.273 , pp. 28419-28423
    • Amann, K.J.1    Renley, B.A.2    Ervasti, J.M.3
  • 25
    • 33746890578 scopus 로고    scopus 로고
    • Interactions of intermediate filament protein synemin with dystrophin and utrophin
    • Aug 4
    • Bhosle RC, Michele DE, Campbell KP, Li Z, Robson RM. Interactions of intermediate filament protein synemin with dystrophin and utrophin. Biochem Biophys Res Commun. 2006 Aug 4;346:768-77. http://dx.doi.org/10.1016/j.bbrc.2006.05.192.
    • (2006) Biochem Biophys Res Commun , vol.346 , pp. 768-777
    • Bhosle, R.C.1    Michele, D.E.2    Campbell, K.P.3    Li, Z.4    Robson, R.M.5
  • 26
    • 24344453799 scopus 로고    scopus 로고
    • Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19
    • Sep
    • Stone MR, O’Neill A, Catino D, Bloch RJ. Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. Mol Biol Cell. 2005 Sep;16:4280-93. http://dx.doi.org/10.1091/mbc.E05-02-0112.
    • (2005) Mol Biol Cell , vol.16 , pp. 4280-4293
    • Stone, M.R.1    O’Neill, A.2    Catino, D.3    Bloch, R.J.4
  • 29
    • 65649111197 scopus 로고    scopus 로고
    • Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
    • Mar
    • Lai Y, Thomas GD, Yue Y, Yang HT, Li D, Long C, et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest. 2009 Mar;119:624-35. http://dx. doi.org/10.1172/JCI36612.
    • (2009) J Clin Invest , vol.119 , pp. 624-635
    • Lai, Y.1    Thomas, G.D.2    Yue, Y.3    Yang, H.T.4    Li, D.5    Long, C.6
  • 30
    • 84872175513 scopus 로고    scopus 로고
    • Alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding
    • Nov 26
    • Lai Y, Zhao J, Yue Y, Duan D. alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding. Proc Natl Acad Sci U S A. 2013 Nov 26;110:525-30. http://dx.doi.org/10.1073/pnas.1211431109
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 525-530
    • Lai, Y.1    Zhao, J.2    Yue, Y.3    Duan, D.4
  • 31
    • 84887723955 scopus 로고    scopus 로고
    • Molecular clues to the dystrophin-nNOS interaction: A theoretical approach
    • Giudice E, Molza A-E, Laurin Y, Nicolas A, Le Rumeur E, Delalande O. Molecular clues to the dystrophin-nNOS interaction: a theoretical approach. Biochemistry. 2013;52:7777-84. http://dx.doi.org/10.1021/bi400794p.
    • (2013) Biochemistry , vol.52 , pp. 7777-7784
    • Giudice, E.1    Molza, A.-E.2    Laurin, Y.3    Nicolas, A.4    Le Rumeur, E.5    Delalande, O.6
  • 32
    • 72949107797 scopus 로고    scopus 로고
    • The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b
    • Nov 26
    • Yamashita K, Suzuki A, Satoh Y, Ide M, Amano Y, Masuda-Hirata M, et al. The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b. Biochem Biophys Res Commun. 2010 Nov 26;391:812-7. http://dx.doi.org/10.1016/j. bbrc.2009.11.144.
    • (2010) Biochem Biophys Res Commun , vol.391 , pp. 812-817
    • Yamashita, K.1    Suzuki, A.2    Satoh, Y.3    Ide, M.4    Amano, Y.5    Masuda-Hirata, M.6
  • 33
    • 0037458618 scopus 로고    scopus 로고
    • Interaction of dystrophin rod domain with membrane phospholipids: Evidence of a close proximity between tryptophan residues and lipids
    • Le Rumeur E, Fichou Y, Pottier S, Gaboriau F, Rondeau-Mouro C, Vincent M, et al. Interaction of dystrophin rod domain with membrane phospholipids: evidence of a close proximity between tryptophan residues and lipids. J Biol Chem. 2003;278:5993-6001. http://dx.doi.org/10.1074/jbc.M207321200.
    • (2003) J Biol Chem , vol.278 , pp. 5993-6001
    • Le Rumeur, E.1    Fichou, Y.2    Pottier, S.3    Gaboriau, F.4    Rondeau-Mouro, C.5    Vincent, M.6
  • 34
    • 40849096281 scopus 로고    scopus 로고
    • Sub-domains of the dystrophin rod domain display contrasting lipid-binding and stability properties
    • Legardinier S, Hubert J-F, Le Bihan O, Tascon C, Rocher C, Raguénès-Nicol C, et al. Sub-domains of the dystrophin rod domain display contrasting lipid-binding and stability properties. Biochim Biophys Acta. 2008;1784:672-82. http://dx.doi.org/10.1016/j. bbapap.2007.12.014.
    • (2008) Biochim Biophys Acta , vol.1784 , pp. 672-682
    • Legardinier, S.1    Hubert, J.-F.2    Le Bihan, O.3    Tascon, C.4    Rocher, C.5    Raguénès-Nicol, C.6
  • 35
    • 65849359061 scopus 로고    scopus 로고
    • Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin
    • Legardinier S, Raguénès-Nicol C, Tascon C, Rocher C, Hardy S, Hubert JF, et al. Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin. J Mol Biol. 2009;389:546-58. http://dx.doi.org/10.1016/j.jmb.2009.04.025.
    • (2009) J Mol Biol , vol.389 , pp. 546-558
    • Legardinier, S.1    Raguénès-Nicol, C.2    Tascon, C.3    Rocher, C.4    Hardy, S.5    Hubert, J.F.6
  • 36
    • 0024600620 scopus 로고
    • Association of dystrophin and an integral membrane glycoprotein
    • Campbell K, Kahl S. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989;338:259-62. http://dx.doi. org/10.1038/338259a0.
    • (1989) Nature , vol.338 , pp. 259-262
    • Campbell, K.1    Kahl, S.2
  • 37
    • 0027275643 scopus 로고
    • A Role for the Dystrophin-Glycoprotein Complex as aTransmembrane Linker between Laminin and Actin
    • Ervasti J, Campbell K. A Role for the Dystrophin-Glycoprotein Complex as aTransmembrane Linker between Laminin and Actin. J Cell Biol. 1993;122:809-23. http://dx.doi.org/10.1083/jcb.122.4.809.
    • (1993) J Cell Biol , vol.122 , pp. 809-823
    • Ervasti, J.1    Campbell, K.2
  • 38
    • 0343081091 scopus 로고    scopus 로고
    • Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan
    • Aug
    • Huang X, Poy F, Zhang R, Joachimiak A, Sudol M, Eck MJ. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat Struct Biol. 2000 Aug;7:634-8. http://dx.doi.org/10.1038/77923.
    • (2000) Nat Struct Biol , vol.7 , pp. 634-638
    • Huang, X.1    Poy, F.2    Zhang, R.3    Joachimiak, A.4    Sudol, M.5    Eck, M.J.6
  • 39
    • 33846886097 scopus 로고    scopus 로고
    • ZZ domain of dystrophin and utrophin: Topology and mapping of a beta-dystroglycan interaction site
    • Feb 1
    • Hnia K, Zouiten D, Cantel S, Chazalette D, Hugon G, Fehrentz JA, et al. ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site. Biochem J. 2007 Feb 1;401:667-77. http://dx.doi.org/10.1042/BJ20061051.
    • (2007) Biochem J , vol.401 , pp. 667-677
    • Hnia, K.1    Zouiten, D.2    Cantel, S.3    Chazalette, D.4    Hugon, G.5    Fehrentz, J.A.6
  • 40
    • 33947722764 scopus 로고    scopus 로고
    • Plectin 1f scaffolding at the sarcolemma of dystrophic (Mdx) muscle fibers through multiple interactions with beta-dystroglycan
    • Mar 26
    • Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C, et al. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol. 2007 Mar 26;176:965-77. http://dx. doi.org/10.1083/jcb.200604179.
    • (2007) J Cell Biol , vol.176 , pp. 965-977
    • Rezniczek, G.A.1    Konieczny, P.2    Nikolic, B.3    Reipert, S.4    Schneller, D.5    Abrahamsberg, C.6
  • 41
    • 57649234553 scopus 로고    scopus 로고
    • An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan
    • Dec 26
    • Ayalon G, Davis JQ, Scotland PB, Bennett V. An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell. 2008 Dec 26;135:1189-200. http://dx.doi.org/10.1016/j. cell.2008.10.018.
    • (2008) Cell , vol.135 , pp. 1189-1200
    • Ayalon, G.1    Davis, J.Q.2    Scotland, P.B.3    Bennett, V.4
  • 42
    • 0030775377 scopus 로고    scopus 로고
    • Dystrobrevin and dystrophin: An interaction through coiled-coil motifs
    • Sadoulet-Puccio H, Rajala M, Kunkel L. Dystrobrevin and dystrophin: An interaction through coiled-coil motifs. Proc Natl Acad Sci USA. 1997;94:12413-8. http://dx.doi.org/10.1073/pnas.94.23.12413.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 12413-12418
    • Sadoulet-Puccio, H.1    Rajala, M.2    Kunkel, L.3
  • 43
    • 0034687238 scopus 로고    scopus 로고
    • Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex
    • Oct 19
    • Newey SE, Benson MA, Ponting CP, Davies KE, Blake DJ. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Curr Biol. 2000 Oct 19;10:1295-8. http://dx.doi.org/10.1016/S0960-9822(00)00760-0.
    • (2000) Curr Biol , vol.10 , pp. 1295-1298
    • Newey, S.E.1    Benson, M.A.2    Ponting, C.P.3    Davies, K.E.4    Blake, D.J.5
  • 44
    • 0023925292 scopus 로고
    • The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle
    • Jun 2
    • Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988 Jun 2;333:466-9. http://dx.doi.org/10.1038/333466a0.
    • (1988) Nature , vol.333 , pp. 466-469
    • Zubrzycka-Gaarn, E.E.1    Bulman, D.E.2    Karpati, G.3    Burghes, A.H.4    Belfall, B.5    Klamut, H.J.6
  • 45
    • 84961045285 scopus 로고    scopus 로고
    • Costamere proteins and their involvement in myopathic processes
    • Jaka O, Casas-Fraile L, Lopez de Munain A, Saenz A. Costamere proteins and their involvement in myopathic processes. Expert Rev Mol Med. 2015;17:e12. http://dx.doi.org/10.1017/erm.2015.9.
    • (2015) Expert Rev Mol Med , vol.17
    • Jaka, O.1    Casas-Fraile, L.2    Lopez De Munain, A.3    Saenz, A.4
  • 46
    • 0038190993 scopus 로고    scopus 로고
    • Costameres: The Achilles’ heel of Herculean muscle
    • Apr 18
    • Ervasti JM. Costameres: the Achilles’ heel of Herculean muscle. J Biol Chem. 2003 Apr 18;278:13591-4. http://dx.doi.org/10.1074/jbc. R200021200.
    • (2003) J Biol Chem , vol.278 , pp. 13591-13594
    • Ervasti, J.M.1
  • 48
    • 0037391465 scopus 로고    scopus 로고
    • Lateral force transmission across costameres in skeletal muscle
    • Apr
    • Bloch RJ, Gonzalez-Serratos H. Lateral force transmission across costameres in skeletal muscle. Exerc Sport Sci Rev. 2003 Apr;31:73-8. http://dx.doi.org/10.1097/00003677-200304000-00004.
    • (2003) Exerc Sport Sci Rev , vol.31 , pp. 73-78
    • Bloch, R.J.1    Gonzalez-Serratos, H.2
  • 49
    • 0347915657 scopus 로고    scopus 로고
    • Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers
    • Jan
    • Kumar A, Khandelwal N, Malya R, Reid MB, Boriek AM. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. Faseb J. 2004 Jan;18:102-13. http://dx.doi.org/10.1096/fj.03-0453com.
    • (2004) Faseb J , vol.18 , pp. 102-113
    • Kumar, A.1    Khandelwal, N.2    Malya, R.3    Reid, M.B.4    Boriek, A.M.5
  • 50
    • 17644402075 scopus 로고    scopus 로고
    • Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies
    • Bloch RJ, Reed P, O’Neill A, Strong J, Williams M, Porter N, et al. Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies. J Muscle Res Cell Motil. 2004;25:590-2.
    • (2004) J Muscle Res Cell Motil , vol.25 , pp. 590-592
    • Bloch, R.J.1    Reed, P.2    O’Neill, A.3    Strong, J.4    Williams, M.5    Porter, N.6
  • 51
    • 17644402075 scopus 로고    scopus 로고
    • Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies
    • Bloch RJ, Reed P, O’Neill A, Strong J, Williams M, Porter N, et al. Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies. J Muscle Res Cell Motil. 2004;25:590-2.
    • (2004) J Muscle Res Cell Motil , vol.25 , pp. 590-592
    • Bloch, R.J.1    Reed, P.2    O’Neill, A.3    Strong, J.4    Williams, M.5    Porter, N.6
  • 52
    • 0035975968 scopus 로고    scopus 로고
    • Muscular degeneration in the absence of dystrophin is a calcium-dependent process
    • Oct 30
    • Mariol MC, Segalat L. Muscular degeneration in the absence of dystrophin is a calcium-dependent process. Curr Biol. 2001 Oct 30;11:1691-4. http://dx.doi.org/10.1016/S0960-9822(01)00528-0.
    • (2001) Curr Biol , vol.11 , pp. 1691-1694
    • Mariol, M.C.1    Segalat, L.2
  • 53
    • 0036127393 scopus 로고    scopus 로고
    • Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
    • Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nature Med. 2002;8:253-61. http://dx.doi.org/10.1038/nm0302-253.
    • (2002) Nature Med , vol.8 , pp. 253-261
    • Harper, S.Q.1    Hauser, M.A.2    Dellorusso, C.3    Duan, D.4    Crawford, R.W.5    Phelps, S.F.6
  • 54
    • 0025159208 scopus 로고
    • Very mild muscular dystrophy associated with the deletion of 46% of the dystrophin
    • England S, Nicholson L, Johnson M, Forrest S, Love D, Zubrzycka-Gaarn E, et al. Very mild muscular dystrophy associated with the deletion of 46% of the dystrophin. Nature. 1990;343:180-2. http://dx.doi.org/10.1038/343180a0.
    • (1990) Nature , vol.343 , pp. 180-182
    • England, S.1    Nicholson, L.2    Johnson, M.3    Forrest, S.4    Love, D.5    Zubrzycka-Gaarn, E.6
  • 55
    • 84862631856 scopus 로고    scopus 로고
    • Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors
    • Jun
    • Seto JT, Ramos JN, Muir L, Chamberlain JS, Odom GL. Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr Gene Ther. 2012 Jun;12:139-51. http://dx.doi.org/10.2174/156652312800840603.
    • (2012) Curr Gene Ther , vol.12 , pp. 139-151
    • Seto, J.T.1    Ramos, J.N.2    Muir, L.3    Chamberlain, J.S.4    Odom, G.L.5
  • 56
    • 84878016335 scopus 로고    scopus 로고
    • Therapy for Duchenne muscular dystrophy: Renewed optimism from genetic approaches
    • Jun
    • Fairclough RJ, Wood MJ, Davies KE. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet. 2013 Jun;14:373-8. http://dx.doi.org/10.1038/nrg3460.
    • (2013) Nat Rev Genet , vol.14 , pp. 373-378
    • Fairclough, R.J.1    Wood, M.J.2    Davies, K.E.3
  • 57
    • 84891922503 scopus 로고    scopus 로고
    • New developments in the use of gene therapy to treat Duchenne muscular dystrophy
    • Feb
    • Jarmin S, Kymalainen H, Popplewell L, Dickson G. New developments in the use of gene therapy to treat Duchenne muscular dystrophy. Expert Opin Biol Ther. 2014 Feb;14:209-30. http://dx.doi.org /10.1517/14712598.2014.866087.
    • (2014) Expert Opin Biol Ther , vol.14 , pp. 209-230
    • Jarmin, S.1    Kymalainen, H.2    Popplewell, L.3    Dickson, G.4
  • 58
    • 84929145979 scopus 로고    scopus 로고
    • Animal models of Duchenne muscular dystrophy: From basic mechanisms to gene therapy
    • Mar
    • McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech. 2015 Mar;8:195-213. http://dx.doi. org/10.1242/dmm.018424.
    • (2015) Dis Model Mech , vol.8 , pp. 195-213
    • McGreevy, J.W.1    Hakim, C.H.2    McIntosh, M.A.3    Duan, D.4
  • 59
    • 41149172666 scopus 로고    scopus 로고
    • Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice
    • Apr
    • Gregorevic P, Blankinship MJ, Allen JM, Chamberlain JS. Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol Ther. 2008 Apr;16:657-64. http://dx.doi.org/10.1038/mt.2008.28.
    • (2008) Mol Ther , vol.16 , pp. 657-664
    • Gregorevic, P.1    Blankinship, M.J.2    Allen, J.M.3    Chamberlain, J.S.4
  • 60
    • 54949097323 scopus 로고    scopus 로고
    • Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer
    • Nov
    • Foster H, Sharp PS, Athanasopoulos T, Trollet C, Graham IR, Foster K, et al. Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer. Mol Ther. 2008 Nov;16:1825-32. http://dx.doi.org/10.1038/mt.2008.186.
    • (2008) Mol Ther , vol.16 , pp. 1825-1832
    • Foster, H.1    Sharp, P.S.2    Athanasopoulos, T.3    Trollet, C.4    Graham, I.R.5    Foster, K.6
  • 61
    • 10044240371 scopus 로고    scopus 로고
    • Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
    • Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan J, Garcia L, et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science. 2004;306. http://dx.doi. org/10.1126/science.1104297.
    • (2004) Science , pp. 306
    • Goyenvalle, A.1    Vulin, A.2    Fougerousse, F.3    Leturcq, F.4    Kaplan, J.5    Garcia, L.6
  • 62
    • 33845667857 scopus 로고    scopus 로고
    • Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides
    • Oct
    • Aartsma-Rus A, Janson AA, Heemskerk JA, De Winter CL, Van Ommen GJ, Van Deutekom JC. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides. Ann N Y Acad Sci. 2006 Oct;1082:74-6. http://dx.doi.org/10.1196/annals.1348.058.
    • (2006) Ann N Y Acad Sci , vol.1082 , pp. 74-76
    • Aartsma-Rus, A.1    Janson, A.A.2    Heemskerk, J.A.3    De Winter, C.L.4    Van Ommen, G.J.5    Van Deutekom, J.C.6
  • 64
    • 33646671717 scopus 로고    scopus 로고
    • Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy
    • May
    • Takeshima Y, Yagi M, Wada H, Ishibashi K, Nishiyama A, Kakumoto M, et al. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Pediatr Res. 2006 May;59:690-4. http://dx.doi.org/10.1203/01.pdr.0000215047.51278.7c.
    • (2006) Pediatr Res , vol.59 , pp. 690-694
    • Takeshima, Y.1    Yagi, M.2    Wada, H.3    Ishibashi, K.4    Nishiyama, A.5    Kakumoto, M.6
  • 65
    • 33745479703 scopus 로고    scopus 로고
    • Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
    • Oct
    • McClorey G, Moulton HM, Iversen PL, Fletcher S, Wilton SD. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 2006 Oct;13:1373-81. http://dx.doi.org/10.1038/sj.gt.3302800.
    • (2006) Gene Ther , vol.13 , pp. 1373-1381
    • McClorey, G.1    Moulton, H.M.2    Iversen, P.L.3    Fletcher, S.4    Wilton, S.D.5
  • 66
    • 84869086454 scopus 로고    scopus 로고
    • Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping
    • Nov
    • Vulin A, Barthelemy I, Goyenvalle A, Thibaud JL, Beley C, Griffith G, et al. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping. Mol Ther. 2012 Nov;20:2120-33. http://dx.doi.org/10.1038/mt.2012.181.
    • (2012) Mol Ther , vol.20 , pp. 2120-2133
    • Vulin, A.1    Barthelemy, I.2    Goyenvalle, A.3    Thibaud, J.L.4    Beley, C.5    Griffith, G.6
  • 67
    • 84884980372 scopus 로고    scopus 로고
    • Muntoni F. 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8-10 December 2012, Naarden, The Netherlands
    • Nov
    • Aartsma-Rus A, Muntoni F. 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8-10 December 2012, Naarden, The Netherlands. Neuromuscul Disord. 2013 Nov;23:934-44. http://dx. doi.org/10.1016/j.nmd.2013.06.369.
    • (2013) Neuromuscul Disord , vol.23 , pp. 934-944
    • Aartsma-Rus, A.1
  • 68
    • 84964313862 scopus 로고    scopus 로고
    • Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients
    • Nov
    • Le Guiner C, Montus M, Servais L, Cherel Y, Francois V, Thibaud JL, et al. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients. Mol Ther. 2014 Nov;22:1923-35. http://dx.doi. org/10.1038/mt.2014.151.
    • (2014) Mol Ther , vol.22 , pp. 1923-1935
    • Le Guiner, C.1    Montus, M.2    Servais, L.3    Cherel, Y.4    Francois, V.5    Thibaud, J.L.6
  • 70
    • 69949107887 scopus 로고    scopus 로고
    • Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study
    • Oct
    • Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, et al. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 2009 Oct;8:918-28. http://dx.doi. org/10.1016/S1474-4422(09)70211-X.
    • (2009) Lancet Neurol , vol.8 , pp. 918-928
    • Kinali, M.1    Arechavala-Gomeza, V.2    Feng, L.3    Cirak, S.4    Hunt, D.5    Adkin, C.6
  • 72
    • 80051690306 scopus 로고    scopus 로고
    • Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
    • Aug 13
    • Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011 Aug 13;378:595-605. http://dx.doi.org/10.1016/S0140-6736(11)60756-3.
    • (2011) Lancet , vol.378 , pp. 595-605
    • Cirak, S.1    Arechavala-Gomeza, V.2    Guglieri, M.3    Feng, L.4    Torelli, S.5    Anthony, K.6
  • 73
    • 84856546632 scopus 로고    scopus 로고
    • Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
    • Nov 15
    • Cirak S, Feng L, Anthony K, Arechavala-Gomeza V, Torelli S, Sewry C, et al. Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy. Mol Ther. 2011 Nov 15.
    • (2011) Mol Ther
    • Cirak, S.1    Feng, L.2    Anthony, K.3    Arechavala-Gomeza, V.4    Torelli, S.5    Sewry, C.6
  • 75
    • 84933673405 scopus 로고    scopus 로고
    • The emperor’s new dystrophin: Finding sense in the noise
    • May 23
    • Wilton SD, Veedu RN, Fletcher S. The emperor’s new dystrophin: finding sense in the noise. Trends Mol Med. 2015 May 23. http://dx.doi.org/10.1016/j.molmed.2015.04.006.
    • (2015) Trends Mol Med
    • Wilton, S.D.1    Veedu, R.N.2    Fletcher, S.3
  • 76
    • 84925456001 scopus 로고    scopus 로고
    • Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45
    • Jan 21
    • Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, et al. Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol. 2015 Jan 21;77:668-74. http://dx.doi.org/10.1002/ana.24365.
    • (2015) Ann Neurol , vol.77 , pp. 668-674
    • Findlay, A.R.1    Wein, N.2    Kaminoh, Y.3    Taylor, L.E.4    Dunn, D.M.5    Mendell, J.R.6
  • 77
    • 84924455392 scopus 로고    scopus 로고
    • Becker muscular dystrophy severity is linked to the structure of dystrophin
    • Oct 27
    • Nicolas A, Raguenes-Nicol C, Ben Yaou R, Ameziane-Le Hir S, Cheron A, Vie V, et al. Becker muscular dystrophy severity is linked to the structure of dystrophin. Hum Mol Genet. 2015 Oct 27;24:1267-79. http://dx.doi.org/10.1093/hmg/ddu537.
    • (2015) Hum Mol Genet , vol.24 , pp. 1267-1279
    • Nicolas, A.1    Raguenes-Nicol, C.2    Ben Yaou, R.3    Ameziane-Le Hir, S.4    Cheron, A.5    Vie, V.6
  • 78
    • 77957685944 scopus 로고    scopus 로고
    • MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway
    • Oct 6
    • Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010 Oct 6;12:341-51. http://dx.doi.org/10.1016/j.cmet.2010.07.008.
    • (2010) Cell Metab , vol.12 , pp. 341-351
    • Cacchiarelli, D.1    Martone, J.2    Girardi, E.3    Cesana, M.4    Incitti, T.5    Morlando, M.6
  • 79
    • 79551594779 scopus 로고    scopus 로고
    • MiR-31 modulates dystrophin expression: New implications for Duchenne muscular dystrophy therapy
    • Feb
    • Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, Santini T, et al. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep. 2011 Feb;12:136-41. http://dx.doi.org/10.1038/embor.2010.208.
    • (2011) EMBO Rep , vol.12 , pp. 136-141
    • Cacchiarelli, D.1    Incitti, T.2    Martone, J.3    Cesana, M.4    Cazzella, V.5    Santini, T.6
  • 80
    • 0033784271 scopus 로고    scopus 로고
    • Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy
    • Kerst B, Mennerich D, Schuelke M, Stoltenburg-Didinger G, von Moers A, Gossrau R, et al. Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy. Neuromuscul Disord. 2000;10:572-7. http://dx.doi.org/10.1016/S0960-8966(00)00150-4.
    • (2000) Neuromuscul Disord , vol.10 , pp. 572-577
    • Kerst, B.1    Mennerich, D.2    Schuelke, M.3    Stoltenburg-Didinger, G.4    Von Moers, A.5    Gossrau, R.6
  • 81
    • 0033972161 scopus 로고    scopus 로고
    • Myoferlin, a candidate gene and potential modifier of muscular dystrophy
    • Jan 22
    • Davis DB, Delmonte AJ, Ly CT, McNally EM. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet. 2000 Jan 22;9:217-26. http://dx.doi.org/10.1093/hmg/9.2.217
    • (2000) Hum Mol Genet , vol.9 , pp. 217-226
    • Davis, D.B.1    Delmonte, A.J.2    Ly, C.T.3    McNally, E.M.4
  • 82
    • 78751634526 scopus 로고    scopus 로고
    • SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
    • Jan 18
    • Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, et al. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology. 2011 Jan 18;76:219-26. http://dx.doi. org/10.1212/WNL.0b013e318207afeb.
    • (2011) Neurology , vol.76 , pp. 219-226
    • Pegoraro, E.1    Hoffman, E.P.2    Piva, L.3    Gavassini, B.F.4    Cagnin, S.5    Ermani, M.6
  • 83
    • 84866252725 scopus 로고    scopus 로고
    • Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
    • Jul 10
    • Bello L, Piva L, Barp A, Taglia A, Picillo E, Vasco G, et al. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology. 2012 Jul 10;79:159-62. http://dx.doi. org/10.1212/WNL.0b013e31825f04ea.
    • (2012) Neurology , vol.79 , pp. 159-162
    • Bello, L.1    Piva, L.2    Barp, A.3    Taglia, A.4    Picillo, E.5    Vasco, G.6
  • 84
    • 84878390222 scopus 로고    scopus 로고
    • LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy
    • Apr
    • Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, et al. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol. 2013 Apr;73:481-8 http://dx.doi.org/10.1002/ana.23819.
    • (2013) Ann Neurol , vol.73 , pp. 481-488
    • Flanigan, K.M.1    Ceco, E.2    Lamar, K.M.3    Kaminoh, Y.4    Dunn, D.M.5    Mendell, J.R.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.